Masaaki Hirata

Dr. Masaaki Hirata


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SYShintaro Yagi
Shintaro Yagi
MHMasaaki Hirata
Masaaki Hirata
YMYosuke Miyachi
Yosuke Miyachi
SUShinji Uemoto
Shinji Uemoto
The liver is a unique organ with an abundant regenerative capacity. Therefore, partial hepatectomy (PHx) or partial liver transplantation (PLTx) can be safely performed. Liver regeneration involves a complex network of numerous hepatotropic factors, cytokines, pathways, and transcriptional factors. Compared with liver regeneration after a viral- or drug-induced liver injury, that of post-PHx or -PLTx has several distinct features, such as hemodynamic changes in portal venous flow or pressure, tissue ischemia/hypoxia, and hemostasis/platelet activation. Although some of these changes also occur during liver regeneration after a viral- or drug-induced liver injury, they are more abrupt and drastic following PHx or PLTx, and can thus be the main trigger and driving force of liver regeneration. In this review, we first provide an overview of the molecular biology of liver regeneration post-PHx and -PLTx. Subsequently, we summarize some clinical conditions that negatively, or sometimes positively, interfere with liver regeneration after PHx or PLTx, such as marginal livers including aged or fatty liver and the influence of immunosuppression.


30 May 2025 in Cell Reports Medicine
Verified
Journal Article
Open access
MHMasaaki Hirata
Masaaki Hirata
KTKazuto Tsukita
Kazuto Tsukita
TSTakero Shindo
Takero Shindo
SYShintaro Yagi
Shintaro Yagi
TITakashi Ito
Takashi Ito
EHEtsuro Hatano
Etsuro Hatano
Donor-specific antibodies (DSAs) against human leukocyte antigen (HLA) play a crucial role in antibody-mediated rejection, a major barrier to successful organ transplantation. Donor-recipient HLA molecular incompatibility critically influences DSA susceptibility, commonly assessed by analyzing mismatches in the HLA eplet repertoire. This study, including six distinct liver, lung, and kidney transplant cohorts from two centers (978 donor-recipient pairs), explores associations between individual eplet mismatches and DSA development. Certain mismatched eplets are strongly linked to DSA development, while others show weaker associations, a trend consistent across different organ types. Machine learning leverages these hierarchical associations to develop an eplet risk score (ERS), outperforming traditional eplet mismatch assessments. Furthermore, T cell proliferation in mixed lymphocyte reaction in vitro correlates with the ERS, attenuated by antibody-mediated inhibition of a mismatched DSA-associated eplet. These results establish the differential immunological impacts of mismatched HLA eplets as integral in clinical practice and therapeutic innovation.

15 November 2022 in European Surgical Research
Verified
Journal Article
Open access
PDF file
MHMasaaki Hirata
Masaaki Hirata
SYShintaro Yagi
Shintaro Yagi
TITakashi Ito
Takashi Ito
YMYuki Masano
Yuki Masano
SOShinya Okumura
Shinya Okumura
EHEtsuro Hatano
Etsuro Hatano
Although rat liver transplantation (LT) is useful in training surgeons to perform microsurgery, mastering these surgical techniques remains difficult. Systematized training protocols that enable learning of the proper skills in a short period of time are needed. The present study describes an efficient five-step rat LT training protocol for surgeons designed to be mastered within 3 months through continuous training. The first step was to review all procedures by watching full videos of rat LT and to watch actual LT operations performed by a skilled surgeon, enabling recognition of the anatomy of rat abdominal organs. The second step was to perform ten donor operations, including ex vivo graft preparation, to learn the atraumatic and delicate techniques. The third step was to perform ten LTs, with the goal of achieving an anhepatic time <20 min and surviving until the next day. The fourth step was to perform ten additional LTs, with the goal of achieving 7 days of survival. The fifth step was to perform 5–10 more LTs, with the goal of achieving 7 days of survival in five consecutive LT operations. Systematizing the training was found to increase its efficiency. Furthermore, determining the specific number of operations in advance is useful to maintain motivation for training. Mastering efficient rat LT will not only enhance the success of preclinical research but will enable young surgeons to better perform vascular anastomoses under a microscope in humans.

9 July 2025 in Liver Transplantation
Verified
Journal Article
Closed access
SYSiyuan Yao
Siyuan Yao
MHMasaaki Hirata
Masaaki Hirata
TITakashi Ito
Takashi Ito
HAHikaru Aoki
Hikaru Aoki
RURyuji Uozumi
Ryuji Uozumi
EHEtsuro Hatano
Etsuro Hatano
Background: While simultaneous splenectomy (SPX) is an option in selected cases of living donor liver transplantation (LDLT) to protect graft function, graft-to-spleen volume ratio (GSVR) may serve as a new determinant of SPX. A prospective validation study was conducted to test our institutional strategy of SPX based mainly on GSVR, which has been employed since 2019. Methods: This prospective study enrolled 141 LDLT recipients from 2019 to 2024. The indication for SPX was GSVR ≤0.70 and high-risk patients (ABO-incompatibility or donor age ≥45 y) with a final portal venous pressure >15 mmHg. Surgical outcomes related to graft function were evaluated and compared between the group with SPX (n=51), the group without SPX (n=90), and the historical control group without SPX despite GSVR of ≤0.70 (from 2007 to 2018, n=33). The risk factors for early allograft dysfunction (EAD) in the modern era were also investigated. Results: Low GSVR indicated 88.2% (45 out of 51) of SPX in the prospective cohort. The historical group (no-SPX despite GSVR ≤0.70) showed an increased incidence of EAD with post-transplant thrombocytopenia, cholestasis, coagulopathy, and massive ascites. In contrast, these adverse events decreased significantly after introducing the new selective SPX protocol, with comparable results between the SPX and no-SPX groups in the prospective cohort. The Model for End-stage Liver Disease (MELD) score was the only indicator of EAD in the multivariable analysis after 2019. Conclusions: Selective SPX centered on GSVR is a feasible and practical option in LDLT to screen out high-risk recipients and improve their graft function for EAD prevention. Export

12 October 2022 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
SYSiyuan Yao
Siyuan Yao
SYShintaro Yagi
Shintaro Yagi
MHMasaaki Hirata
Masaaki Hirata
YMYosuke Miyachi
Yosuke Miyachi
EOEri Ogawa
Eri Ogawa
EHEtsuro Hatano
Etsuro Hatano